Continuous glucose monitoring (CGM) in pregnant women with type 1 diabetes was associated with improved neonatal outcomes, according to a trial published in The Lancet.
The 325 women with type 1 diabetes (215 pregnant, 110 planning pregnancy) were randomly assigned to CGM in addition to capillary glucose monitoring or to standard capillary glucose monitoring alone (control).
Anita Slomski. Continuous Glucose Monitoring in Pregnant Women With Diabetes. JAMA. 2017;318(20):1968. doi:10.1001/jama.2017.17951